TrialNCT07503405Phase 2Not yet recruiting
Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model
Study sponsor: Traws Pharma, Inc. · TRAW
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2026-11Estimated
Enrollment · participants165Estimated
Source updated2026-03-31Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.